Clinical Trial Update: Impact of a Human Origin Heat Inactivated Probiotic-Lactobacillus Paracasei D3.5 (LpD3.5) as Dietary Supplement on Gut Mucin and Intestinal Permeability in Adults With IBD [NA]

View source ↗

Summary

Clinical trial update describing a planned study of a heat-inactivated probiotic Lactobacillus paracasei D3.5 (LpD3.5) as a dietary supplement to assess its eff…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Drugs mentioned

• Lactobacillus paracasei D3.5 (LpD3.5) (Lactobacillus paracasei D3.5)

Snippet

Sponsor: University of South Florida | Conditions: Inflammatory Bowel Diseases | NA | Status: NOT_YET_RECRUITING